echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > J Invest Dermatol: Differences in clinical characteristics and comorbidity burden of more than 9,000 psoriasis patients with HLA-C*06:02 carrier group

    J Invest Dermatol: Differences in clinical characteristics and comorbidity burden of more than 9,000 psoriasis patients with HLA-C*06:02 carrier group

    • Last Update: 2021-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Prevention and management of vascular infection with diabetes mellitus metabolic syndrome




    statistics


    Screening

    Overall, this study shows that HLA-C*06:02 is an important biomarker to consider in the future multi-label stratified medicine method


    Literature source: Douroudis K, Ramessur R, Barbosa IA, DIFFERENCES IN CLINICAL FEATURES AND COMORBID BURDEN BETWEEN HLA-C*06:02 CARRIER GROUPS IN MORE THAN 9,000 PEOPLE WITH PSORIASIS, J Invest Dermatol 2021 09; 

    Douroudis K, Ramessur R, Barbosa IA,DIFFERENCES IN CLINICAL FEATURES AND COMORBID BURDEN BETWEEN HLA-C*06:02 CARRIER GROUPS IN MORE THAN 9,000 PEOPLE WITH PSORIASIS, J Invest Dermatol 2021 Nov 09; 

     



    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.